Walmak,Please look at my question and then look at your answer.I rest my case.However, I can only wish them well as I would prefer that IDG shareholders were not hurt any further.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%